PortfolioPortfolio mode

TMO

Thermo Fisherstock

$684.931.65% today

Trade TMO

← Research only mode

Research TMO

TMO · 90-day price history

Market cap

$254.2B

P/E

37.0

Div yield

0.27%

Industry

Diagnostics & Research

Exchange

NYSE

Website ↗

Prediction models

All predictions →

Trend follower

Horizon: 1 week

Signal strength0.72

Historical accuracy55%

99 predictions · 12mBaseline 57%

How this works

Compares a 10-day vs 50-day moving average. When the short-term average rises above the long-term average, the trend is up.

Not financial advice. Past accuracy does not guarantee future results.

Momentum

Horizon: 1 week

flat

Signal strength0.07

Historical accuracy37%

99 predictions · 12mBaseline 57%

How this works

Uses RSI (a gauge of recent buying/selling intensity) and 5-day rate-of-change to judge whether the stock has been pushed too far in one direction.

Not financial advice. Past accuracy does not guarantee future results.

Statistical trend

Horizon: 1 month

Signal strength0.70

Historical accuracy62%

81 predictions · 12mBaseline 76%

How this works

Fits a trend line through the last 60 days of prices and measures how far the current price has strayed from it.

Not financial advice. Past accuracy does not guarantee future results.

Multi-factor + news

Horizon: 1 week

AI + NEWS

Signal strength0.35

Historical accuracy65%

37 predictions · 12mBaseline 57%

Accuracy reflects technical signals only. News sentiment is live.

How this works

Combines trend (25%), momentum (25%), volume (15%), and AI-analysed news sentiment (35%) from your trusted sources into one score.

Not financial advice. Past accuracy does not guarantee future results.

Bull / Bear thesis

AI analysis

Bull case●

Life sciences tools market growing rapidly

DNA sequencing and cell therapy markets expanding

Price action

AI is accelerating research tool adoption

AI-driven pharma R&D increasing demand

Price action

Strong 1.64% gain reflects positive sentiment

Outperforming broader market

Price action

Bear case●

Modest stock gain despite favorable news

1.64% suggests already-priced-in expectations

Price action

Competition in life sciences tools intensifying

Illumina and others competing aggressively

Price action

Pharma spending on R&D is discretionary

Economic slowdown could cut research budgets

Price action

AI-generated from recent news and price action. Not financial advice. Educational only.

Seasonality

~5y of history

Avg return by month · %

This month historically: -1.05% on average, up 60% of 5 years.

Avg return by weekday · %

Historical pattern only — seasonality is not a prediction and often breaks.

Recent news

No recent news found for TMO.

AI research companion

AI Research Companion

Loading…